FEIHE Officially Approved to Enter Indonesian Market: The First Formula Milk with Fresh Milk as Main Ingredient


Feihe: Sole Enterprise Invited to "Bridging Minds" 2026 Advances in Neurodevelopment and Mental Health (ANTARA/Business Wire)

Jakarta, Indonesia--(ANTARA/Business Wire)--Feihe, a leading Chinese infant formula brand, has officially received approval for its “AceKid Activegro” series to enter the Indonesian market. This marks the first formula milk product in Indonesia to use fresh milk as its core ingredient. Prior to this, Feihe entered the Philippine market in 2025 and has since expanded to nearly 500 retail outlets.

Indonesia enforces stringent regulatory standards for imported infant food products. This approval serves as official recognition of Feihe’s product quality. The AceKid Activegro series utilizes a “One-step Process” that transforms fresh milk directly into powder, effectively preserving and locking in natural nutrients.

In addition, AceKid adheres to a natural nutritional formula, containing no added sucrose, maltodextrin, vanillin, or corn syrup. This approach aims to help maintain stable blood sugar levels in infants and support digestive health. The core principle is to provide pure, natural nutrition—supporting physical and cognitive development while minimizing the risk of tooth decay and the development of a preference for sweetness.

Recently, the “Bridging Minds—2026 Advances in Neurodevelopment and Mental Health” was held at NUS. Co-organized by the BCH-Feihe Pediatric Brain Development Initiative, the Neuroscience & Behavioural Disorders Programme at Duke-NUS Medical School, Boston Children’s Hospital, and Harvard Medical School, the summit brought together experts from leading global universities to discuss cutting-edge topics in brain nutrition and cognitive development.

Feihe’s partnership with Harvard spans more than a decade. In 2023, the two parties established the BCH-Feihe Pediatric Brain Development Initiative to advance research on the effects of genetics, nutrition, and the environment on early childhood brain development. Today, Feihe has established deep collaborations with more than 40 research platforms across seven countries. In North America, the company built Canada’s first infant formula manufacturing facility, bringing China’s fully integrated dairy industry model and standards to developed markets. “We are transitioning from a learner in global research to a participant, and even a definer,” said Leng Youbin, Chairman of Feihe.

Contacts

Wangyang Fang
2876170025@qq.com
https://www.feihe.com/?mz_ca=2301537&mz_sp=8Atx6


Penulis : Adityawarman